Drugs in development for autoimmune diseases in the United States 2016 by all types

Number of medicines in development for Autoimmune Diseases in the United States as of 2016, by all types

The data displays number of medicines in development for autoimmune diseases in United States as of 2016, by all types. For arthritis there were almost 76 medicines in development and awaiting review by the U.S. Food and Drug Administration (FDA) as of September 2016.

Autoimmune arthritis 76
Inflammatory bowel disease 58
Psoriasis 48
Lupus 39
Diabetes, type1 34
Multiple sclerosis 32
Scleroderma 13
Sjögren's syndrome 9
Neuromyelitis optica 5
Myasthenia gravis 5
Pemphigus 5
Celiac disease 5
Primary biliary cholangitis 4
Immune thrombocytopenia 4
Dermatomyositis 3
Glomerulonephritis 3
CIDP 3
Other diseases 18
Nonspecific diseases 17